QCBGX
Price
$23.02
Change
+$0.07 (+0.31%)
Updated
Sep 15 closing price
Net Assets
292.72M
RLBCX
Price
$38.39
Change
+$0.07 (+0.18%)
Updated
Sep 15 closing price
Net Assets
263.06B
Interact to see
Advertisement

QCBGX vs RLBCX

Header iconQCBGX vs RLBCX Comparison
Open Charts QCBGX vs RLBCXBanner chart's image
Federated Hermes MDT Balanced C
Price$23.02
Change+$0.07 (+0.31%)
VolumeN/A
Net Assets292.72M
American Funds American Balanced R3
Price$38.39
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets263.06B
QCBGX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QCBGX vs. RLBCX commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCBGX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 263B vs. QCBGX (293M). RLBCX pays higher dividends than QCBGX: RLBCX (1.53) vs QCBGX (0.61). QCBGX was incepted earlier than RLBCX: QCBGX (20 years) vs RLBCX (23 years). QCBGX (2.12) is less costly to investors than RLBCX (0.89). QCBGX is a more actively managed with annual turnover of: 68.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than QCBGX: RLBCX (250) vs QCBGX (1500). RLBCX annual gain was more profitable for investors over the last year : 9.50 vs. QCBGX (4.02). RLBCX return over 5 years is better than : 40.28 vs. QCBGX (20.58).
QCBGXRLBCXQCBGX / RLBCX
Total Expense Ratio2.120.89238%
Annual Report Gross Expense Ratio2.120.89238%
Fund Existence20 years23 years-
Gain YTD10.81613.07183%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets293M263B0%
Annual Yield % from dividends0.611.5340%
Returns for 1 year4.029.5042%
Returns for 3 years25.6642.1461%
Returns for 5 years20.5840.2851%
Returns for 10 years49.3876.0665%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WNC11.370.20
+1.79%
Wabash National Corp
NGVT58.690.54
+0.93%
Ingevity Corp
APVO1.44-0.03
-2.04%
Aptevo Therapeutics Inc
INCR1.53-0.04
-2.40%
Intercure Ltd
BAH101.62-3.00
-2.87%
Booz Allen Hamilton Holding Corp